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Abstract The interleukin-1 gene family encodes a group
of related proteins that exhibit a remarkable pleiotropy in
the context of health and disease. The set of indispensable
functions they control suggests that these genes should be
found in all eukaryotic species. The ligands and receptors
of this family have been primarily characterised in man
and mouse. The genomes of most non-mammalian animal
species sequenced so far possess all of the IL-1 receptor
genes found in mammals. Yet, strikingly, very few of the
ligands are identifiable in non-mammalian genomes. Our
recent identification of two further IL-1 ligands in the
chicken warranted a critical reappraisal of the evolution
of this vitally important cytokine family. This review
presents substantial data gathered across multiple, diver-
gent metazoan genomes to unambiguously trace the origin
of these genes. With the hypothesis that all of these genes,
both ligands and receptors, were formed in a single an-
cient ancestor, extensive database mining revealed suffi-
cient evidence to confirm this. It therefore suggests that
the emergence of mammals is unrelated to the expansion
of the IL-1 family. A thorough review of this cytokine
family in the chicken, the most extensively studied
amongst non-mammalian species, is also presented.
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Introduction
In humans, the IL-1 family contains 11 ligand genes (Table 1)
encoded at three separate loci. Nine of these are present at a
single locus on chromosome 2, whereas IL-18 and IL-33 lie
on chromosomes 11 and 9, respectively. The ligands were
originally named IL-1 F1-F11; however, this nomenclature
has recently been revised ((Dinarello et al. 2010); see Table 1).
Ligand members have a broad and sometimes overlapping
range of prominent roles in innate and adaptive immune
responses. They are thought to have arisen following gene
duplication, which is reflected in their many shared character-
istics. The specific bioactivities, expression, regulation and
genomic organisation of these 11 ligands have been compre-
hensively characterised in mammals (Boraschi et al. 2011;
Dinarello 2009; Dinarello 2011; Towne and Sims 2012; van
de Veerdonk et al. 2012; Vigne et al. 2012).
The biological effects of the IL-1 ligands are mediated by
members of the IL-1 receptor (IL-1R) family which are
expressed on the surface of target cells or secreted as soluble
receptors. In mammals, the family has 11 members (Table 2)
that are characterised by an IgG-like extracellular domain and a
cytoplasmic Toll/IL-1R (TIR) domain. The IL-1R family is part of
a wider superfamily of TIR domain-containing receptors which
includes the Toll-like receptors, intracellular adaptor molecules
(such as MyD88), which are involved in signalling and pattern
recognition, and the Toll proteins of Drosophila.
In this review, we discuss our findings from an analysis of
the chicken IL-1 family. Moreover, we consider, alongside a
genomic analysis of other species, the significance of these
data with regard to the evolution of IL-1 in vertebrates.
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The chicken IL-1 family
Compared with mammals, far fewer members of the IL-1
family have been identified in the chicken. To date, the ligands
IL-1β, IL-1RN, IL-36RN and IL-18, as well as the receptors
IL-1RI and ST2, are the only chicken orthologues that have
been cloned. Analysis of chicken SIGIRR messenger RNA
(mRNA) expression has been carried out by northern blot but
the complementary DNA (cDNA) has not been cloned.
Chicken orthologues of IL-18Rα, IL-1RAcP and TIGIRR-1
have also been identified from expressed sequence tag (EST)
libraries, but have not been fully characterised.
Chicken IL-1β
The first chicken IL-1 (chIL-1) ligand to be identified was
chIL-1β, and its cDNA was cloned from lipopolysaccha-
ride (LPS)-stimulated HD11 (an avian macrophage cell
line) cells (Weining et al. 1998). It encodes a predicted
protein of 267 amino acids which has 25 % identity with
its human orthologue and contains an NH2-terminal pro-
domain. Mammalian IL-1β is synthesised as a biological-
ly inactive molecule containing a pro-domain (Jobling
et al. 1988), which is cleaved by caspase-1 at a conserved
aspartic acid residue (Black et al. 1988) facilitating secre-
tion. Caspase-1 activation is dependent upon assembly of
the NALP3 inflammasome (Agostini et al. 2004). The
chicken orthologue of caspase-1 has also been cloned
(Johnson et al. 1998), suggesting that a mechanism for
chIL-1β (and chIL-18) maturation similar to that in mam-
mals may be used. Unlike mammalian IL-1β, the chicken
protein lacks a conserved aspartic acid at the predicted
caspase-1 cut site. Purified recombinant mature chIL-1β
(lacking the predicted pro-domain) exhibited biological
activity which resembled that of its mammalian
orthologues. In CEC-32 cells (a quail fibroblast cell line)
stimulated with rchIL-1β, a dose-dependent increase in
Table 1 The IL-1 ligand gene family in humans
Gene name Alternative names Biological function Genomic location
Interleukin-1α IL-1A, IL1, IL-1α, IL1F1 Agonist 2: 113,531,492–113,542,167
Interleukin-1β IL-1B, IL-1β, IL1F2 Agonist 2: 113,587,328–113,594,480
Interleukin-1 receptor antagonist ICIL-1RA, IL-1RN, IL1F3, IL1RA,
IRAP, MGC10430
Receptor antagonist 2: 113,864,791–113,891,593
Interleukin-18 IGIF, IL-18, IL-1 g, IL1F4 Agonist 11: 112,013,974–112,034,840
Interleukin-36 receptor antagonist FIL1, FIL1δ, FIL1D, IL-1 F5,
IL1F5, IL1HY1, IL1L1, IL1RP3,
IL-36RN, IL36RA, MGC29840
Receptor antagonist;
anti-inflammatory
2: 113,816,215–113,822,325
Interleukin-36α FIL1, FIL1E, IL-1 F6, IL1ε, IL1F6,
IL-36A, IL-36α, MGC129552,
MGC129553
Agonist 2: 113,763,038–113,765,621
Interleukin-37 FIL1, FIL1ζ, FIL1Z, IL-1 F7, IL-1H4,
IL-1RP1, IL1F7, IL-37
Anti-inflammatory 2: 113,670,548–113,676,459
Interleukin-36β FIL1, FILIη, IL-1 F8, IL-1H2, IL1-ETA,
IL1F8, IL1H2, MGC126880,
MGC126882, IL-36B, IL-36β
Agonist 2: 113,779,668–113,810,444
Interleukin-36γ IL-1 F9, IL-1H1, IL-1RP2, IL1E,
IL1F9, IL1H1, IL-36G, IL-36γ
Agonist 2: 113,730,780–113,743,242
Interleukin-38 FKSG75, IL-1 F10, IL-1HY2, IL1-theta,
MGC11983, MGC119832,
MGC119833, IL-38
Receptor antagonist 2: 113,825,547–113,833,427
Interleukin-33 C9orf26, DKFZp586H0523, DVS27,
IL1F11, NF-HEV, IL-33
Agonist 9: 6,215,805–6,257,983
Table 2 The IL-1 receptor gene family in humans and chickens. Six
members of the family are found at a locus that has conserved synteny
between the two species
Gene Genomic location
Human Chicken
IL-1RII 2: 102,608,306–102,645,006 1: 133,109,396–133,119,021
IL-1RIa 2: 102,681,004–102,796,334 1: 133,163,682–133,185,156
IL-1RL2 2: 102,803,433–102,856,462 1: 138,039,834–138,053,899
ST2 2: 102,927,962–102,968,497 1: 133,190,561–133,209,036
IL-18Rα 2: 102,927,989–103,015,218 1: 133,259,701–133,278,851
IL-18Rβ 2: 103,035,149–103,069,025 1: 133,283,645–133,298,556
SIGIRR 11: 405,716–417,455 5: 1,555,415–1,560,214
TIGIRR1 X: 103,810,996–105,012,102 4: 16,972,376–17,142,642
TIGIRR2 X: 28,605,516–29,974,840 1: 115,540,657–115,874,541
IL-1RAcP 3: 190,231,840–190,375,843 9: 13,337,288–13,367,409
TILRR 9: 14,734,664–14,910,993 Z: 31,576,518–31,643,574
a The recently identified IL-1R3 (Qian et al. 2012) is a truncated IL-1RI
transcript formed through the use of an internal promoter
Immunogenetics
CXCLi1 (K60) expression was detected. Similar to mam-
malian IL-1β, an instability element (ATTTA) was iden-
tified in the 3′ untranslated region (UTR) of the chIL-1β
transcript (Weining et al. 1998). Compared with full-
length chIL-1β and three alternatively truncated forms,
an N-terminal truncation mutant of chIL-1β starting im-
mediately 5′ to Ala106 (the first residue after the predicted
caspase-1 cleavage site) exhibited significantly enhanced
(100-fold) bioactivity (Gyorfy et al. 2003). This suggests
that processing is required for maximal chIL-1β activity,
possibly mediated by caspase-1. A recent study has
shown that chIL-1β can be processed at three alternative
aspartic acid residues (D77, D80, D82) with sea bass
caspase-1 (Reis et al. 2012). Using site-directed mutagen-
esis, the genuine caspase-1 cut site was confirmed as D80.
Both human and sea bass caspase-1 cleave chicken pro-
IL-1β at this position (Reis et al. 2012). In mammals,
caspase-1-independent processing of IL-1β is carried out
by several neutrophil proteases (Dinarello 2011). Adjacent
to the caspase-1 site, single tyrosine and alanine residues
have been recognised as the protease cut sites in mammals
(Dinarello 2011). Although avian equivalents of the neu-
trophil proteases have yet to be identified in heterophils
(counterpart of mammalian neutrophils), their putative cut
sites are both conserved in chIL-1β.
Expression of chIL-1β is increased in response to
bacterial, viral and parasite challenge, consistent with
its role as a rapidly induced pro-inflammatory mediator.
In IFN-γ-pr imed heterophils , s t imulat ion with
Salmonella Enteritidis led to statistically significant in-
creases in IL-1β expression (Kogut et al. 2005). Simi-
larly, in chicken embryonic fibroblasts (CEF), kidney
cells and HD11 cells, stimulation with Salmonella-de-
rived flagellin induced significant increases in IL-1β
expression in all three cell types (Iqbal et al. 2005).
IL-1β expression is also increased in bursal cells from
IBDV-infected chickens (Eldaghayes et al. 2006) as well
as in HD11 cells stimulated with TLR7 agonists
(Philbin et al. 2005). Intraepithelial lymphocytes re-
moved from the jejunum of Eimeria maxima-infected
chickens contain high levels of IL-1β mRNA compared
with uninfected controls (Hong et al. 2006).
The structure of the chIL-1β gene has been elucidated
(Kaiser et al. 2004). The exon-intron structure of mammalian
IL-1β is conserved in the chicken; however, the overall size of
the chicken gene is substantially smaller than the human
orthologue due to much shorter introns throughout. The crystal
structure of chIL-1β has recently been resolved (Cheng et al.
2011), revealing that the β-trefoil conformation of the human
cytokine is conserved in the chicken. Significant differences
between the chicken and human structures were found in the
regions involved in receptor binding, providing a molecular
explanation for the inability of these cytokines to cross-react.
Chicken IL-18
A full-length chicken IL-18 open reading frame (ORF) was
identified in a bursal EST library and subsequently cloned
from LPS-stimulated HD11 cells (Schneider et al. 2000). The
full-length predicted protein contains 199 amino acids (aa),
has 30 % identity with mammalian chIL-18 sequences and
includes a pro-domain at the NH2-terminal. When aligned
with mammalian sequences, a conserved aspartic acid is ap-
parent at the predicted caspase-1 cleavage site, suggesting that
it may be processed by the enzyme. Purified recombinant
mature chIL-18 (lacking the pro-domain) exhibited biological
activity similar to that of mammalian IL-18. In primary chick-
en splenocytes stimulated with rchIL-18, a dose-dependent
increase in IFN-γ production was detected (Schneider et al.
2000). A conserved Th1 cell lineage similar to the one in
mammals was subsequently proposed in the chicken. In chick-
en CD4+ splenocytes stimulated with chIL-18, cell prolifera-
tion, IFN-γ production and MHC class II expression were all
increased (Gobel et al. 2003). This was dependent upon the
presence of macrophages in the culture (Gobel et al. 2003).
Elevated levels of IL-18 mRNA have been detected in the
spleen of birds infected with Marek’s disease virus (Kaiser
et al. 2003), characteristic of a pro-inflammatory response to
viral infection. IL-18 expression was also increased in the
spleen of birds injected with Salmonella Typhimurium LPS
(Sijben et al. 2003) and the heterophils of chickens treated
with corticosterone (Shini et al. 2010), reflecting the typical
pro-inflammatory role of this cytokine.
Chicken IL-1RN
Interleukin-1 receptor antagonist (IL-1RN) is a naturally oc-
curring receptor antagonist that inhibits IL-1-mediated inflam-
mation. In mammals, two major structural variants of this
gene, secretory and intracellular, are formed through alterna-
tive splicing. The secretory variant limits the bioactivity of IL-
1α and IL-1β through cell surface (type I IL-1) receptor
blocking, whilst the intracellular isoforms, although clearly
antagonistic, may function through any of three inadequately
defined mechanisms. Firstly, icIL-1RNmay suppress intracel-
lular signalling in a non-classical (non-IL-1R-dependent)
manner (Banda et al. 2005). Secondly, icIL-1RN may com-
pete with IL-1α in the nucleus to inhibit the effects of the
agonist (Merhi-Soussi et al. 2005). Thirdly, icIL-1RN iso-
forms may be released from cells and bind to membrane-
bound IL-1RI to limit IL-1 activity, in a similar way to sIL-
1RN (Corradi et al. 1995; Evans et al. 2006; Levine et al.
1997; Yoon et al. 1999). The gene for IL-1RN can been found
in the genome of over 30 mammalian species and, for years,
remained undiscovered in the non-mammalian lineage. How-
ever, given the potency of IL-1β in immune responses, the
identification of chIL-1β (Weining et al. 1998) suggested that
Immunogenetics
IL-1RNwould also be present in this species. Although absent
from every assembled build of the chicken genome thus far,
transcripts corresponding to both secretory and intracellular
variants of chIL-1RN were identified from the NCBI EST
database and subsequently cloned from LPS-stimulated HD11
cells (Gibson et al. 2012a). The sIL-1RN and icIL-1RN cod-
ing region cDNAs encode predicted proteins of 173 and
163 aa, respectively, although sIL-1RN contains a predicted
17 aa signal peptide, so its predicted secreted mature protein is
156 aa. Chicken sIL-1RN is very similar in length to human
sIL-1RN, sharing 38.3 % aa identity, whilst chicken icIL-
1RN, most similar to the human icIL-1RN1 isoform, has
38.2 % aa identity with the human equivalent (Gibson et al.
2012a). The human IL-1RN gene consists of six exons, which,
through differential splicing of the first three exons (ic1, ic2
and s1), creates three different transcripts: sIL-1RN, icIL-
1RN1 and icIL-1RN2. The structure of the chIL-1RN gene
is similar to its human orthologue, but is comprised of five
exons, which, when translated, result in isoforms very similar
in size to the corresponding human proteins. The introns of the
chIL-1RN gene, however, are significantly smaller than their
human equivalents, resulting in the overall gene length being
around one tenth that of huIL-1RN (Gibson et al. 2012a).
Both recombinant full-length chIL-1RN isoforms
antagonised the IL-1β-mediated upregulation of IL-1β and
iNOS genes, mirroring their function in mammals (Gibson
et al. 2012a). Further splice variants of both major structural
variants were also identified, which, despite being formed
through well-known splicing mechanisms (exon-skipping
and use of an alternative splice acceptor site) were structurally
different to mammalian splice forms and yielded non-
functional proteins (Gibson et al. 2012a).
Chicken IL-1RN (full-length) expression is increased
in vivo following bacterial or viral infection, reflecting a
typical response to that seen in experimental models of disease
inmammalian species. Stimulation of three distinct monocyte/
macrophage populations with LPS in vitro did not affect the
expression of full-length chIL-1RN, an unexpected response
that differs from previous observations in human monocytes
(Gibson et al. 2012a).
Chicken IL-36RN
Mammalian IL-36RN suppresses inflammation through its
role as an IL-1RL2 (IL-1Rrp2) receptor antagonist (Debets
et al. 2001; Towne et al. 2011; Vigne et al. 2011). This
prevents the agonists—IL-36α, IL-36β and IL-36γ—from
binding this receptor to initiate gene transcription via NF-kB
and MAP kinases. Similar to IL-1RN, IL-36RN is unable to
recruit IL-1RAcP on the cell surface (Towne et al. 2011). IL-
36RN also interacts with the orphan receptor SIGIRR to
downregulate inflammation through an as yet unelucidated
mechanism (Costelloe et al. 2008). The gene for IL-36RN is
present in the genome sequence of over 30 mammalian spe-
cies and was previously proposed to have arisen following
gene duplication from IL-1RN in the ancestral species of the
mammalian lineage (Mulero et al. 2000). The chicken is the
only non-mammalian species in which it has been identified to
date (Gibson et al. 2012b). As with chIL-1RN, it is currently
unidentifiable in the chicken genome and was uncovered
through mining the NCBI EST database. Its predicted aa
sequence most closely resembles IL-36RN following
TBLASTN analysis of all the available mammalian genome
sequences. Amoderate degree of aa identity (31.2 %) between
the predicted chIL-36RN sequence and human and mouse IL-
36RN was found (Gibson et al. 2012b). Additional in silico
analyses supported the BLAST results to unequivocally es-
tablish its identity. Phylogenetic analysis was able to confirm
that it is distantly related to mammalian IL-36RN. Analysis of
the predicted secondary structure of chIL-36RN identified 12
β-strands located in almost identical regions to those in mouse
IL-36RN, thus far the only experimentally resolved IL-36RN
structure (Gibson et al. 2012b). ChIL-36RN is encoded by a
six-exon gene, consisting of four coding region exons with the
5′ UTR comprised of two further exons. The human
orthologue shares this exonic structure; however, it has a
much longer 3′ UTR and its intron sizes differ from those of
the chicken gene.
Human IL-36RN appears to be processed non-classically
with recent data, suggesting that proteolytic cleavage yields a
mature protein with increased specific activity (Towne et al.
2011). The protein does not possess a signal peptide like IL-
1RN, nor have an obvious pro-domain like IL-1β and IL-1α.
Instead, the fully active protein simply lacks the NH2-terminal
methionine; a mechanism to explain its removal remains
unknown. Mammalian IL-36 cytokines exhibit maximal ac-
tivity when processed exactly nine residues upstream of a
conserved three aa motif. In the huIL-36RN sequence, this
equates to cleavage between the start codon and an adjacent
valine residue (Towne et al. 2011). Although a similar three aa
motif is conserved in chIL-36RN, there is no evidence that the
same mode of processing (and specific activity thereafter) is
also conserved in birds, as chIL-36RN has a much longer
NH2-terminus than the human protein.
Chicken IL-36RN mRNA expression levels were signifi-
cantly increased following infection with Salmonella
Typhimurium. However, in an infectious bursal disease virus
challenge model, a striking decrease in chIL-36RN mRNA
expression levels was observed. This trend was evident in
birds that were either resistant or susceptible to this virus,
though the largest relative differences in expression were
observed between infected and uninfected susceptible birds.
A role for this cytokine in response to viral challenge has yet
to be documented in mammals.
Whilst all other analyses of chIL-36RN suggested that its
identity had been correctly ascribed, characterisation of its
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bioactivity did not yield findings similar to those observed for
huIL-36RN. This was principally due to the absence of IL-
1RL2 agonist ligands in the chicken, which would be required
to facilitate a more comprehensive assessment of function.
Chicken IL-1RI
The type I chicken IL-1 receptor (chIL-1RI) was cloned from
a primary chicken fibroblast cDNA library. When compared
with its human and mouse orthologues, amino acid identity of
the five major protein domains varied from 19 to 61 %, with
the cytoplasmic domain the most highly conserved region
(Guida et al. 1992). A bioactive form of soluble chIL-1RI
(sIL-1RI) has also been cloned (Klasing and Peng 2001).
Chicken ST2
The chicken orthologue of the ST2 receptor was cloned
from cDNA isolated from chicken embryos (Iwahana et al.
2004). Three different cDNAs were identified and designat-
ed ST2, ST2L and ST2 LV. ST2 is the secreted, soluble form
of the receptor of which a homologue has also been identi-
fied in humans. ST2L is a longer, membrane-bound isoform
which contains a transmembrane domain, whilst ST2LV is a
novel splice variant of the ST2L transcript. ST2LV lacks the
transmembrane domain present in ST2L and as such is a
secreted protein. To date, this novel splice variant has not
been found in any mammalian species. ST2L has 39.3 and
38.3 % aa identity with its respective human and mouse
orthologues. In all three species, ST2L contains a signal
peptide of similar length and all six cysteine residues are
conserved in the Ig-like domain region. The structures of the
human and chicken ST2 genes are very similar (Iwahana
et al. 2004). The ligand for this receptor, IL-33, has yet to be
identified in the chicken.
Chicken SIGIRR (TIR8)
A full-length chicken SIGIRR transcript with 86 % nucleotide
identity with human SIGIRR was identified in the NCBI
nucleotide database (Riva et al. 2009). Northern blotting anal-
ysis of 21 different chicken tissues revealed that the expres-
sion was ubiquitous with relatively high levels in the kidney,
small and large intestine, caecum, liver, glandular stomach
and cloaca (Riva et al. 2009). A splice variant was identified
exclusively in the adrenal gland. No further analyses of this
gene have been performed.
Other chIL-1 receptors
In humans, the IL-1RII, IL-1RI, IL-1RL2, ST2, IL-18Rα and
IL-18Rβ genes lie in a cluster on chromosome 2 in that order
(Fig. 1). An examination of conserved synteny between this
cluster and the chicken genome revealed that the huIL-1R
gene cluster is fully conserved in the chicken genome on
chromosome 1 (1: 133,109,396–133,298,556) (Fig. 1). Previ-
ous studies reporting the identification and cloning of chIL-
1RI (Guida et al. 1992) and chST2 (Iwahana et al. 2004) failed
to determine a genomic location. A partial chIL-18Rα EST
had already been identified (Huising et al. 2004); however,
chicken orthologues of IL-1RII and IL-18Rβ had never been
described. Other members of the huIL-1R family reside else-
where in the genome, necessitating analysis of conserved
synteny between the two species to identify the remaining
chIL-1R genes. The chicken gene for SIGIRR/TIR8 is on
chromosome 5, at a locus that is highly conserved with the
SIGIRR/TIR8 locus on human chromosome 11. Full-length
chicken cDNAs of two other IL-1 receptors (TIGIRR1,
TIGIRR2) and two IL-1 co-receptors (IL-1RAcP and
TILRR) found in humans had never been isolated. Again,
conserved synteny was used to identify these genes in the
chicken. They are dispersed across the genome, as they are in
Fig. 1 Schematic depicting the IL-1 receptor gene family locus with complete conserved synteny between humans and chickens
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humans. Human TIGIRR1/IL-1RAPL2, found on human
chromosome X, has a chicken orthologue on chromosome
4 (4: 16,972,376–17,142,642). Only a partial chTIGIRR-1
EST had been previously identified (Huising et al. 2004).
Human TIGIRR2/IL-1RAPL1, which is also found on
chromosome X, has an orthologue in the chicken genome
on chromosome 1 (1: 115,540,657–115,874,541). Human
IL-1RAcP is found on chromosome 3 at a locus syntenic
with a region of chicken chromosome 9, which contains
the chIL-1RAcP gene (9: 13,337,288–13,367,409). A par-
tial chIL-1RAcP EST had been previously identified
(Huising et al. 2004) but unmapped in the genome.
TILRR, a novel IL-1RI co-receptor recently discovered
in human and mouse genomes (Zhang et al. 2010), also
has a chicken orthologue. The human gene lies on chro-
mosome 9, with the chicken gene present on chromosome
Z (Z: 31,576,518–31,643,574). Syntenic loci for all five
receptors are depicted in Fig. 2. Thus, our analysis has
shown that all of the IL-1 receptor genes found in the
human genome are also present in the chicken. By contrast, only
4 of the 11 IL-1 ligand genes present in the human genome have
been identified in the chicken. This discrepancy is particularly
striking when the crucial functional roles of these mammalian
ligand genes (Nold et al. 2010; Schmitz et al. 2005; Towne and
Fig. 2 IL-1 receptor gene loci conserved between the chicken and human genomes. Direct IL-1R orthologues have identical shading. Both SIGIRR and
IL-1RAcP loci lie in the reverse orientation in the chicken genome. NRK on human Chr. X is a MAP4K4 paralogue
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Sims 2012; Vigne et al. 2012) apparently “missing” in the
chicken are considered.
Evolution of the IL-1 family in vertebrates
The past decade has yielded a significant volume of nucleotide
sequence data, furthering our knowledge and understanding
of the repertoires of immune function genes in many verte-
brates. The availability of multiple novel genome builds,
improved versions of existing builds and accompanying tran-
scriptome datasets has enabled meaningful comparisons to be
made regarding the evolution of certain gene families. In two
previous studies (Huising et al. 2004; Subramaniam et al.
2004), thorough phylogenetic and molecular analyses of the
known members of the IL-1 family in mammals, fish and
chicken were described. Here we build on these findings by
focussing on a genomic analysis of the ligands and receptors
across a more diverse range of species.
Ligands
Nine of the 11 known IL-1 ligand genes are present at a single
locus in the majority of sequenced mammalian genomes. Ro-
dents, who lack IL-37 and whose IL-1α and IL-1β genes are
separated from the other six genes by ~105Mb of sequence on
Chr. 2, are the only notable exception to this amongst mam-
mals (Nicklin et al. 2002; Taylor et al. 2002). As such, when
considered alongside the many other characteristics shared by
these genes, it has been suggested that this gene family arose
through successive gene duplications (Busfield et al. 2000;
Eisenberg et al. 1991; Nicklin et al. 2002; Taylor et al. 2002).
By contrast, it is not possible to make the same inference
for non-mammalian species. Examination of conserved
synteny between the human and chicken genome showed that
the nine gene IL-1 cluster in humans is represented by only a
single chicken IL-1 gene, IL-1β, at the equivalent chicken
locus. Despite excellent supporting evidence from other non-
mammalian species (Fig. 3), the most recent build of the
Fig. 3 Schematic depicting an IL-1 ligand gene family locus with a
degree of conserved synteny in the human, chicken, puffer fish, Chinese
soft turtle and anole lizard genomes. Eight of the flanking genes found at
IL-1 gene loci in non-mammalian species are conserved at a single locus
on human chromosome 7. In the anole lizard, BLAST analysis (Gibson
et al. 2012a) indicates IL-1FA, IL-1FB and IL-1FC are IL-1RN, IL-36RN
and IL-38, though their exact identities cannot be determined with con-
fidence. IL-1FD is homologous to IL-1FA-C; however, it is not clear
which huIL-1 F orthologue it most closely resembles. Direct orthologues
have identical shading
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chicken genome (v4.0) no longer places chIL-1β on chromo-
some 22. It is now unplaced in v4.0, and where it was mapped
on Chr. 22 in the previous genome build (v2.1), there is now a
large gap in the current build. The degree of conserved
synteny with the other non-mammalian species suggests that
the v2.1 build is correct at Chr. 22, and the new assembly of
this chromosome is incomplete. The chicken also possesses
two receptor antagonist genes, IL-1RN and IL-36RN, which
have yet to be mapped in the genome but are not at the same
locus as chIL-1β (Gibson et al. 2012a; Gibson et al. 2012b).
This represents a major difference between the chicken and
mammals. In the puffer fish, the softshell turtle and anole
lizard genomes, similar conserved IL-1 gene loci exist
(Fig. 3). As in the chicken, all contain fewer IL-1 genes than
the mammalian IL-1 locus; however, each possesses conserved
flanking genes that they share with at least three other species.
The number of direct orthologues shared at these syntenic loci
between this divergent group of species (Fig. 3) suggests a
common origin. In fact, the position of the CKAP2L gene,
which effectively “tethers” IL-1β in most mammalian and
non-mammalian species (data not shown), indicates that an
ancestral “founder” locus existed even before the divergence of
birds and mammals over 310 million years ago.
So, has this group of non-mammalian species ever pos-
sessed (or do they still possess) the remaining “missing” genes
that are seen in mammals? It is possible that the multi-IL-1
gene locus found in most mammals was formed through
duplication in the mammalian lineage. Alternatively, these
genes may have been present in an ancestor and have since
become lost and/or dispersed in non-mammalian species. We
have also previously discussed the possibility of an alternative
model of gene duplication (Gibson et al. 2012a). In this
model, an ancient IL-1 locus with a small number of genes
(e.g. IL-1β and IL-1RN) was duplicated. Further duplications
led to differential expansion of paralogous IL-1 loci in differ-
ent species. Species-specific mutations and/or deletions could
then have followed this to produce the IL-1 loci we now see in
these different species. In our analysis of chIL-1RN, we
discussed whywe think it emerged following gene duplication
from a common ancestor; however, we did so by only com-
paring the chicken and human orthologues (Gibson et al.
2012a). In this review, our analysis has now been expanded
to include IL-1RN in reptiles and an IL-1β antagonist in
teleost fish (Wang et al. 2009). From this, we can conclude
that the presence of IL-1RN in the chicken and anole lizard as
well as a teleost IL-1β antagonist gene, at different loci to IL-
1β in their respective genomes, confirms that at least one
ancestral IL-1 gene duplication occurred prior to a major
rearrangement event. The large number of non-IL-1 direct
orthologues shared between the five species in Fig. 3 suggests
that this duplication preceded speciation and took place in a
common ancestor. The number of confirmed structural and
functional similarities between chIL-1RN and huIL-1RN
(Gibson et al. 2012a) further supports this theory, i.e. that
mammalian IL-1RN genes also originated from the same
primordial gene and not following the emergence of mam-
mals. Although possible, it seems implausible that all IL-1RN
orthologues identified thus far have emerged as products of
species-specific convergent evolution.
Recently, a small number of publications have outlined
some important roles played by other IL-1 family members
(Mutamba et al. 2012; Ramadas et al. 2012; van de Veerdonk
et al. 2012; Vigne et al. 2011; Vigne et al. 2012). Of note, the
IL-36 agonists have the capacity to shape the adaptive im-
mune response through their effects upon CD4+ Tcells (Vigne
et al. 2011). The presence of the IL-36 receptor (IL-1RL2) and
IL-36RN genes in both the chicken and anole lizard genomes
strongly implies that at least one IL-36 agonist gene must have
Fig. 4 Schematic depicting the IL-33 locus in the human genome and a
conserved syntenic region of the chicken genome. Avian orthologues of
two of the genes (RANBP6 and TPD52L3) on human chromosome 9 lie
elsewhere in the chicken genome. An IL-33 gene has yet to be identified
in the chicken genome. Pairs of orthologous genes are indicated with lines
and have identical shading
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been present in the ancestral species. Both of these species
currently have poorly assembled genomes with regions of low
coverage and contain many large gaps in regions that are
difficult to sequence. Should either or both retain IL-36 ago-
nist genes, the analysis of their structure, function and geno-
mic locations could strengthen the notion of a multi-IL-1 gene
“founder” locus. One of the other IL-1 family ligand members
yet to be identified in the chicken is IL-33, yet the gene which
encodes its receptor, ST2, is conserved in the chicken genome
in a location syntenic with the human orthologue. Several
other non-mammals possess this receptor (data not shown).
Examining conserved synteny between the human IL-33 gene
locus and the chicken genome does not identify an avian
orthologue. Despite this, conserved synteny between large
numbers of genes flanking huIL-33 and a region on chicken
chromosome Z is evident (Fig. 4). When evaluating pairings
of the direct orthologues shared between both species at this
locus (Fig. 4), it is clear that a chromosomal breakpoint has
occurred and a potential chIL-33 gene has been lost or
relocated. An examination of anole lizard, softshell turtle
and tetraodon genomes shows that a number of the genes in
this cluster on chicken Chr. Z are also conserved at syntenic
loci in those species (data not shown). This suggests that the
mammalian IL-33 locus and its conserved syntenic loci in
non-mammalian species may have a shared, ancient origin.
This therefore indicates that the mammalian IL-33 locus re-
flects the ancestral one and has probably been rearranged in
non-mammalian species, should this IL-1 family member
have ever existed within that lineage. Although IL-33 has only
been found in mammals thus far, it was conceivably present in
the common ancestor of all vertebrates when this locus was
formed.
Receptors
The IL-1 receptor genes of mammalian and non-mammalian
species are remarkably well conserved despite millions of
years of divergent evolution. Several IL-1R genes with con-
served TIR and extracellular Ig domains were previously
analysed in mammals, chicken and fish (Huising et al. 2004;
Subramaniam et al. 2004). However, a lack of genomic se-
quence for many of these species meant these studies, whilst
comprehensive, were incomplete. With an improved build of
the chicken genome now available, we observed that all of the
IL-1R genes found in the human genome are present in the
chicken at conserved loci. As with the IL-1 ligand genes, our
Fig. 5 Phylogenetic analysis of the human (Homo sapiens: Hs), mouse
(Mus musculus: Mm), chicken (Gallus gallus: Gg), anole lizard (Anolis
carolinesis: Ac) and Chinese softshell turtle (Pelodiscus sinensis: Ps) IL-1
receptor aa sequences using MEGAv6.0. Analysis was performed using
the neighbor-joining method with bootstrap analysis with 500 bootstrap
datasets
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analysis was extended to other non-mammalian species,
which revealed a similar degree of receptor gene conservation.
At the major IL-1 receptor gene locus, examining conserved
synteny between the human, chicken, anole lizard and soft-
shell turtle genomes showed that the latter two species possess
all six genes found in man and birds (Supplementary Table 1).
The locus is split between scaffolds in the turtle, with an
additional IL-1RL2-like gene also apparent. The degree of
structural similarity between IL-1R paralogues and direct
orthologues (Huising et al. 2004) implies the major IL-1R
gene cluster arose following successive duplication events.
Furthermore, conservation at the DNA level across such a
broad range of species suggests that these genes are under a
strong selective pressure and likely to retain an indispensable
and, between orthologues, homologous function. Phylogenet-
ic analysis of the IL-1R genes in human, mouse, chicken,
anole lizard and softshell turtle confirms the receptors in all
three non-mammalian species have a common origin they
share with mammals (Fig. 5). It will be interesting to deter-
mine whether intracellular signalling pathways are also con-
served in each of these non-mammalian species.
Although all of the IL-1R family share sequence homology
and conserved functional domains, it is interesting to note that
four members are “isolated” at loci separate from the main six-
gene cluster. The level of similarity across the family indicates
all ten of the IL-1R genes arose from a common ancestral gene
as we (and others) have proposed for the ligands. We investi-
gated this possibility further, and report here for the first time a
single observation to partially support this theory. Immediate-
ly adjacent to the IL-1R2 gene at the chicken and human
major IL-1R loci is an unrelated mitogen-activated protein
kinase gene (MAP4K4). This gene has a number of
paralogues within the genomes of both these species, and
one is found on chromosomes 4 and X in the chicken and
human, respectively. This particular paralogue is directly
flanked by IL-1RAPL2 (Fig. 6). To establish if this observa-
tion was restricted to a limited number of species, we
scrutinised the genomes of further species and found that the
same genomic structure exists in several fish, platypus,
Xenopus and numerous mammals (data not shown). In addi-
tion to IL-1RAPL2 and MAP4K4, there are four additional
unrelated genes, all of which, strikingly, possess a paralogue
close to the major IL-1R gene locus (Fig. 6). Thus, there is
profound evidence of duplication at a single region prior to
chromosomal rearrangement and IL-1R gene duplication at
the major IL-1R locus. Some of these additional unrelated
genes (MAP4K4, TBC1D8, RNF149, NPAS2 and LONRF3)
are also found at the IL-1RAPL2 loci in fish, platypus,
Xenopus and other mammalian genomes (data not shown)
confirming that the duplications have ancient origins.
Concluding remarks
In this review, we utilised improved genomic resources along-
side our experimental findings in the chicken to further our
understanding of the evolution of the IL-1 gene family. Since
this subject was last reviewed almost a decade ago (Huising
et al. 2004), our work in the chicken has identified two IL-1
receptor antagonist genes for the first time in a non-
mammalian species (Gibson et al. 2012a; Gibson et al.
2012b). The fact that they reside at an alternative locus to
IL-1β yet retain structural and functional similarities with
their mammalian orthologues suggests that the previous con-
jecture on the evolution of these two receptor antagonists is
likely to be incorrect (Mulero et al. 2000). An IL-1β antago-
nist in rainbow trout (Wang et al. 2009) and three IL-1 genes
in lizards that group with the chicken, human and mouse
receptor antagonists (Gibson et al. 2012a) have also been
identified. When considered alongside a thorough examina-
tion of the genomes of several mammalian and non-
mammalian vertebrates, the most likely explanation for the
evolution of IL-1 ligand genes was the formation of the family
in a common ancestor that preceded speciation. These genes
were then presumably subjected to significant selective
Fig. 6 Schematic depicting paralogous loci on chromosomes 1 and 4 in the chicken genome. Direct paralogues have identical shading
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pressures provided by the distinct set of challenges presented
to an individual species. In the chicken, lizard and rainbow
trout, this seems to have resulted in them becoming dispersed
across the genome. The identification of a single locus, on
human chromosome 7, containingmost of the genes that flank
the IL-1 ligands of non-mammals endorses our view that the
family was formed before speciation.
A concurrent analysis of the receptors of this cytokine
family led us to a broadly similar theory to that proposed for
the ligands—that ancient gene duplications initially formed a
single cohort of receptor genes. The post-speciation evolution
of these receptor genes, however, differs greatly from that of
the ligands. The single major ligand gene locus in mammals
has remained intact but has become fragmented in the ge-
nomes of several non-mammals. The sequences of these li-
gands have also diverged rapidly, presumably in response to
pathogen challenge, such that aa homologies are typically low
(25–40 %) between orthologues. The IL-1 receptor genes of
relatively distant species have remained well conserved at
syntenic loci in their genomes, yet aa sequence identities are
similarly low (30–42 % between humans and chickens)
amongst orthologues at the major IL-1R locus. It is also
interesting to observe that the aa sequence identity between
the IL-1R orthologues isolated at discrete loci (SIGIRR,
TIGIRR-1, TIGIRR-2 and IL-1RAcP) remains relatively high
(56–95 % between humans and chickens). Conservation of
the entire IL-1 receptor gene family in the three non-
mammalian species studied suggests that there may be further
ligand genes to be identified in each.
In conclusion, we believe we have identified evidence to
show the ligands and receptors of the IL-1 cytokine family in
all vertebrates may have evolved from the same ancient an-
cestor. Furthermore, we believe the greater number of ligand
genes identified in mammals is not necessarily the product of
mammalian lineage-specific gene duplication.
Open Access This article is distributed under the terms of the Creative
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